Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022 By: Harrow via Business Wire October 28, 2022 at 08:00 AM EDT Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced that it will release its financial results for the third quarter ended September 30, 2022, on Monday, November 14, 2022, after the market close. The Company will also post its third quarter Letter to Stockholders to the “Investors” section of its website, harrowinc.com. Harrow will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results and provide a business update. Conference Call Details: Date: Monday, November 14, 2022 Time: 4:45 p.m. Eastern time Participant Dial-in: 1-833-953-2434 (U.S.) 1-412-317-5763 (International) Replay Dial-in (Passcode 7735845): (telephonic replay through November 21, 2022) 1-877-344-7529 (U.S.) 1-412-317-0088 (International) Webcast: (online replay through February 14, 2023) harrowinc.com About Harrow Harrow (Nasdaq: HROW) is an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies that are accessible and affordable. For more information about Harrow, including investor-related materials, please visit the corporate website, harrowinc.com, or Harrow’s LinkedIn page. View source version on businesswire.com: https://www.businesswire.com/news/home/20221027005179/en/Contacts Jamie Webb, Director of Communications and Investor Relations jwebb@harrowinc.com 615-733-4737 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Harrow to Announce Third Quarter 2022 Financial Results on November 14, 2022 By: Harrow via Business Wire October 28, 2022 at 08:00 AM EDT Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced that it will release its financial results for the third quarter ended September 30, 2022, on Monday, November 14, 2022, after the market close. The Company will also post its third quarter Letter to Stockholders to the “Investors” section of its website, harrowinc.com. Harrow will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results and provide a business update. Conference Call Details: Date: Monday, November 14, 2022 Time: 4:45 p.m. Eastern time Participant Dial-in: 1-833-953-2434 (U.S.) 1-412-317-5763 (International) Replay Dial-in (Passcode 7735845): (telephonic replay through November 21, 2022) 1-877-344-7529 (U.S.) 1-412-317-0088 (International) Webcast: (online replay through February 14, 2023) harrowinc.com About Harrow Harrow (Nasdaq: HROW) is an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies that are accessible and affordable. For more information about Harrow, including investor-related materials, please visit the corporate website, harrowinc.com, or Harrow’s LinkedIn page. View source version on businesswire.com: https://www.businesswire.com/news/home/20221027005179/en/Contacts Jamie Webb, Director of Communications and Investor Relations jwebb@harrowinc.com 615-733-4737
Harrow (Nasdaq: HROW), an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, today announced that it will release its financial results for the third quarter ended September 30, 2022, on Monday, November 14, 2022, after the market close. The Company will also post its third quarter Letter to Stockholders to the “Investors” section of its website, harrowinc.com. Harrow will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results and provide a business update. Conference Call Details: Date: Monday, November 14, 2022 Time: 4:45 p.m. Eastern time Participant Dial-in: 1-833-953-2434 (U.S.) 1-412-317-5763 (International) Replay Dial-in (Passcode 7735845): (telephonic replay through November 21, 2022) 1-877-344-7529 (U.S.) 1-412-317-0088 (International) Webcast: (online replay through February 14, 2023) harrowinc.com About Harrow Harrow (Nasdaq: HROW) is an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies that are accessible and affordable. For more information about Harrow, including investor-related materials, please visit the corporate website, harrowinc.com, or Harrow’s LinkedIn page. View source version on businesswire.com: https://www.businesswire.com/news/home/20221027005179/en/